FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

395869000: Rosiglitazone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469809014 Rosiglitazone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489507011 Rosiglitazone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1469809014 Rosiglitazone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1469809014 Rosiglitazone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489507011 Rosiglitazone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1489507011 Rosiglitazone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
838851000172110 rosiglitazone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
838851000172110 rosiglitazone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rosiglitazone (substance) Is a Thiazolidinedione (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone (substance) Has disposition Peroxisome proliferator-activated gamma receptor agonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing rosiglitazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone maleate 2mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone maleate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone maleate (substance) Is a False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Metformin- and rosiglitazone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing glimepiride and rosiglitazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet Has basis of strength substance (attribute) True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has basis of strength substance (attribute) True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet Has basis of strength substance (attribute) False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet Has basis of strength substance (attribute) True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has precise active ingredient False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has precise active ingredient False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing rosiglitazone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing metformin and rosiglitazone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Glimepiride- and rosiglitazone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Rosiglitazone maleate (substance) Is modification of (attribute) True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Glimepiride and rosiglitazone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only metformin and rosiglitazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only rosiglitazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Glimepiride and rosiglitazone only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only rosiglitazone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin and rosiglitazone only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has precise active ingredient False Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has basis of strength substance (attribute) True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Glimepiride 1 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has basis of strength substance (attribute) True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Glimepiride 4 mg and rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet Has basis of strength substance (attribute) True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Rosiglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2

Reference Sets

GB English

US English

Back to Start